KBC Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $152M | Sell |
2,420,506
-623,879
| -20% | -$49.9M | 0.38% | 47 |
|
|
2025
Q4 | $290M | Buy |
3,044,385
+84,768
| +3% | +$8.31M | 0.66% | 23 |
|
|
2025
Q3 | $289M | Buy |
2,959,617
+297,044
| +11% | +$30.8M | 0.69% | 20 |
|
|
2025
Q2 | $286M | Buy |
2,662,573
+419,460
| +19% | +$42.4M | 0.77% | 18 |
|
|
2025
Q1 | $226M | Sell |
2,243,113
-137,408
| -6% | -$13.8M | 0.7% | 22 |
|
|
2024
Q4 | $213M | Buy |
2,380,521
+41,720
| +2% | +$3.67M | 0.59% | 25 |
|
|
2024
Q3 | $196M | Buy |
2,338,801
+457,383
| +24% | +$36.1M | 0.59% | 24 |
|
|
2024
Q2 | $145M | Buy |
1,881,418
+153,645
| +9% | +$11.2M | 0.44% | 37 |
|
|
2024
Q1 | $118M | Sell |
1,727,773
-119,912
| -6% | -$7.71M | 0.38% | 57 |
|
|
2023
Q4 | $107M | Sell |
1,847,685
-339,983
| -16% | -$18.1M | 0.38% | 59 |
|
|
2023
Q3 | $116M | Buy |
2,187,668
+45,697
| +2% | +$2.4M | 0.47% | 44 |
|
|
2023
Q2 | $116M | Sell |
2,141,971
-648,629
| -23% | -$33.9M | 0.48% | 46 |
|
|
2023
Q1 | $140M | Sell |
2,790,600
-100,900
| -3% | -$4.76M | 0.59% | 35 |
|
|
2022
Q4 | $134M | Sell |
2,891,500
-1,076,834
| -27% | -$46.6M | 0.65% | 30 |
|
|
2022
Q3 | $154M | Buy |
3,968,334
+240,315
| +6% | +$9.64M | 0.8% | 23 |
|
|
2022
Q2 | $139M | Buy |
3,728,019
+441,604
| +13% | +$18M | 0.69% | 32 |
|
|
2022
Q1 | $146M | Buy |
3,286,415
+357,349
| +12% | +$15.5M | 0.58% | 40 |
|
|
2021
Q4 | $124M | Buy |
2,929,066
+547,827
| +23% | +$23M | 0.41% | 61 |
|
|
2021
Q3 | $103M | Sell |
2,381,239
-1,819,523
| -43% | -$80.5M | 0.38% | 65 |
|
|
2021
Q2 | $180M | Buy |
4,200,762
+942,612
| +29% | +$39.7M | 0.32% | 71 |
|
|
2021
Q1 | $126M | Sell |
3,258,150
-3,776
| -0.1% | -$143K | 0.26% | 92 |
|
|
2020
Q4 | $645M | Sell |
3,261,926
-145,692
| -4% | -$5.25M | 0.28% | 88 |
|
|
2020
Q3 | $130M | Buy |
3,407,618
+260,882
| +8% | +$10.1M | 0.38% | 64 |
|
|
2020
Q2 | $110M | Buy |
3,146,736
+1,691,273
| +116% | +$60.9M | 0.37% | 59 |
|
|
2020
Q1 | $47.5M | Buy |
1,455,463
+409,999
| +39% | +$16M | 0.4% | 54 |
|
|
2019
Q4 | $47.3M | Buy |
1,045,464
+129,912
| +14% | +$5.44M | 0.3% | 71 |
|
|
2019
Q3 | $37.3M | Sell |
915,552
-217,666
| -19% | -$9.22M | 0.27% | 82 |
|
|
2019
Q2 | $48.7M | Buy |
1,133,218
+151,966
| +15% | +$5.85M | 0.38% | 51 |
|
|
2019
Q1 | $37.7M | Buy |
981,252
+68,112
| +7% | +$2.6M | 0.31% | 70 |
|
|
2018
Q4 | $32.3M | Buy |
913,140
+101,885
| +13% | +$3.7M | 0.36% | 67 |
|
|
2018
Q3 | $31.2M | Buy |
811,255
+103,084
| +15% | +$3.6M | 0.24% | 110 |
|
|
2018
Q2 | $23.2M | Sell |
708,171
-2,686
| -0.4% | -$81K | 0.2% | 137 |
|
|
2018
Q1 | $19.4M | Sell |
710,857
-88,997
| -11% | -$2.42M | 0.18% | 151 |
|
|
2017
Q4 | $19.8M | Sell |
799,854
-249,827
| -24% | -$6.89M | 0.17% | 156 |
|
|
2017
Q3 | $30.6M | Buy |
1,049,681
+28,579
| +3% | +$789K | 0.28% | 89 |
|
|
2017
Q2 | $28.3M | Sell |
1,021,102
-38,181
| -4% | -$1.01M | 0.27% | 98 |
|
|
2017
Q1 | $26.3M | Buy |
1,059,283
+31,393
| +3% | +$763K | 0.24% | 98 |
|
|
2016
Q4 | $22.2M | Buy |
1,027,890
+172,049
| +20% | +$3.75M | 0.22% | 112 |
|
|
2016
Q3 | $20.4M | Buy |
855,841
+205,213
| +32% | +$4.9M | 0.24% | 98 |
|
|
2016
Q2 | $15.2M | Sell |
650,628
-16,073
| -2% | -$348K | 0.22% | 118 |
|
|
2016
Q1 | $12.5M | Sell |
666,701
-19,967
| -3% | -$351K | 0.21% | 118 |
|
|
2015
Q4 | $12.7M | Buy |
686,668
+81,203
| +13% | +$1.46M | 0.23% | 120 |
|
|
2015
Q3 | $9.94M | Sell |
605,465
-123,665
| -17% | -$2.11M | 0.2% | 132 |
|
|
2015
Q2 | $12.9M | Buy |
729,130
+448,190
| +160% | +$8.01M | 0.17% | 164 |
|
|
2015
Q1 | $4.99M | Sell |
280,940
-543,988
| -66% | -$8.6M | 0.06% | 310 |
|
|
2014
Q4 | $10.9M | Sell |
824,928
-56,553
| -6% | -$723K | 0.13% | 186 |
|
|
2014
Q3 | $10.4M | Buy |
881,481
+256,768
| +41% | +$3.23M | 0.36% | 54 |
|
|
2014
Q2 | $7.98M | Buy |
624,713
+217,768
| +54% | +$2.83M | 0.09% | 274 |
|
|
2014
Q1 | $5.5M | Sell |
406,945
-240,288
| -37% | -$3.15M | 0.09% | 278 |
|
|
2013
Q4 | $7.78M | Buy |
647,233
+148,853
| +30% | +$1.76M | 0.12% | 233 |
|
|
2013
Q3 | $5.85M | Buy |
498,380
+156,828
| +46% | +$1.7M | 0.09% | 273 |
|
|
2013
Q2 | $3.17M | Buy |
+341,552
| New | +$2.9M | 0.06% | 385 |
|
Other funds holding BSX
VCM
VPM
KBC Group's BSX Position: Q1 2026 in Review
KBC Group reduced its Boston Scientific (BSX) stake by 20% in Q1 2026, selling an estimated $49.9M and leaving 2,420,506 shares worth $152M. The position accounts for 0.38% of the portfolio, ranked #47.
KBC Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $645M in Q4 2020. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- KBC Group held 2,420,506 shares of Boston Scientific worth $152M as of Q1 2026.
- KBC Group sold 623,879 Boston Scientific shares in Q1 2026, an estimated $49.9M.
- Boston Scientific made up 0.38% of KBC Group's portfolio in Q1 2026, its #47 holding.
- KBC Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Boston Scientific position peaked at $645M in Q4 2020.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.